MAL2 and urinary bladder carcinoma: Firstly, the expression levels of MALAT1 (Figure 7A) and MAL2 (Figure 7B) were significantly (p < 0.001) increased, by 2.9‐fold and 3.0‐fold, respectively, in the tumorous tissues of bladder cancer patients, whereas the expression level of miR‐384 (Figure 7C) was significantly (p < 0.001) decreased, by 66.3%, compared with the normal tissues.